784-P: Does Sacubitril/Valsartan Combination Therapy Provide Additional Renal Benefits in Type 2 Diabetes Mellitus Receiving Canagliflozin?

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 784-P
Author(s):  
VISHAL GUPTA ◽  
VAISHALI TELI
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Combination Therapy

Oral combination therapy for type 2 diabetes mellitus

2007 ◽  
Author(s):  
J Navarro ◽  
M Valdivieso ◽  
A Bonet ◽  
A Navarro ◽  
V Gosalbes
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Combination Therapy

Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus

2011 ◽  
Vol 12 (10) ◽  
pp. 1457-1461 ◽  
Author(s):  
Nikolaos Papanas ◽  
Niki Katsiki ◽  
Apostolos I Hatzitolios ◽  
Efstratios Maltezos
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Combination Therapy ◽  
Valuable Component

Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats

2017 ◽  
Vol 1674 ◽  
pp. 1-9 ◽  
Author(s):  
Naveen Shivavedi ◽  
Mukesh Kumar ◽  
Gullanki Naga Venkata Charan Tej ◽  
Prasanta Kumar Nayak
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Ascorbic Acid ◽  
Type 2 Diabetes Mellitus ◽  
Combination Therapy ◽  
Comorbid Depression

scholarly journals Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus

2017 ◽  
Vol 41 (5) ◽  
pp. 357 ◽  
Author(s):  
Min Kyong Moon ◽  
Kyu-Yeon Hur ◽  
Seung-Hyun Ko ◽  
Seok-O Park ◽  
Byung-Wan Lee ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Combination Therapy ◽  
Hypoglycemic Agents ◽  
Oral Hypoglycemic Agents
Sign in / Sign up

Export Citation Format

Share Document